Stay updated with breaking news from Lexaria Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lexaria is targeting the oral nicotine pouch category, one of the fastest growing segments of the nicotine industry.KELOWNA, BC / ACCESSWIRE / July 13, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW)
KELOWNA, BC / ACCESSWIRE / July 7, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its
Expands DehydraTECH B2B manufacturing capabilities to support Lexaria's growing corporate customer baseLexaria to also receive royalty revenue from DehydraTECH product sales through BevNology's commercial
Lundin Mining (OTCMKTS:LUNMF – Get Rating) and Lexaria Bioscience (OTCMKTS:LXRP – Get Rating) are both basic materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends. Analyst Ratings This is a summary of current ratings […]
Lexaria Bioscience Corp. (NASDAQ:LEXX – Get Rating) – Zacks Small Cap upped their Q4 2022 earnings per share estimates for shares of Lexaria Bioscience in a report issued on Wednesday, June 8th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.21) per share for the quarter, up from their prior […]